Dr. Frederick Barrett discusses recent and upcoming studies into psilocybin -- the psychoactive ingredient that puts the "magic" in magic mushrooms.  This currently "Schedule 1" drug, in addition to reasonably reliably provoking mystical experiences in users, also shows promise as a therapeutic treatment for depression, PTSD, and hospice care.  Dr. Barrett and colleagues at Johns Hopkins Medical Center are at the forefront of the latest research.
The post #116: Psilocybin and the Potential for “Psychedelic Therapies” appeared first on Smart Drug Smarts.